Determination of Adenosine Deaminase Binding Domain on CD26 and Its Immunoregulatory Effect on T Cell Activation

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 6070-6076

  Dong, Rui Ping ^a   Tachibana, Kouichi ^a   Hegen, Martin ^a   Munakata, Yasuhiko ^a   Cho, Donny ^a   Schlossman, Stuart F ^a   Morimoto, Chikao ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE IV; IMMUNOLOGICAL ADJUVANT;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; DRUG EFFECT; ENZYMOLOGY; GENE DELETION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE; PHYSIOLOGY; POINT MUTATION; PROTEIN TERTIARY STRUCTURE; RAT; T LYMPHOCYTE;

ADENOSINE DEAMINASE; ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD26; BINDING SITES; GENE DELETION; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RATS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0031573556     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Fox, D. A., R. E. Hussey, K. A. Fitzgerald, O. Acuto, C. Poole, L. Palley, J. F. Daley, S. F. Schlossman, and E. L. Reinherz. 1984. Tal, a novel 105 kD human T cell activation antigen defined by a monoclonal antibody. J. Immunol. 133:1250.
2. Morimoto, C., Y. Torimoto, G. Levinson, C. E. Rudd, M. Schrieber, N. H. Dang, N. L. Letvin, and S. F. Schlossman. 1989. 1F7, a novel cell surface molecule involved in helper function of CD4 cells. J. Immunol. 143:3430.
3. Dang, N. H., Y. Torimoto, K. Deusch, S. F. Schlossman, and C. Morimoto. 1990. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J. Immunol. 144:4092.
4. Tanaka, T., J. Kameoka, A. Yaron, S. F. Schlossman, and C. Morimoto. 1993. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc. Natl. Acad. Sci. USA 90:4586.
5. Tanaka, T., J. S. Duke-Cohan, J. Kameoka, A. Yaron, I. Lee, S. F. Schlossman, and C. Morimoto. 1994. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc. Natl. Acad. Sci. USA 91:3082.
6. Tanaka, T., D. Camerini, B. Seed, Y. Torimoto, N. H. Dang, J. Kameoka, H. N. Dahlberg, S. F. Schlossman, and C. Morimoto. 1992. Cloning and functional expression of the T cell activation antigen, CD26. J. Immunol. 149:481.
7. Torimoto, T., N. H. Dang, E. Vivier, T. Tanaka, S. F. Schlossman, and C. Morimoto. 1991. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J. Immunol. 147:2514.
8. Kameoka, J., T. Tanaka, Y. Nojima, S. F. Schlossman, and C. Morimoto. 1993. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261:466.
9. Vives-Corrons, J. L., C. Rozman, M. A. Pujades, D. Colomer., E. Perez-Vila. I. Anegon, T. Gallart, J. Vives-Puiggros, N. Viñolas, and E. Montserrat. 1988. Combined assay of adenosine deaminase, purine nucleoside phosphorylase, and lactate dehydrogenase in the early clinical evaluation of B-chronic lymphocytic leukemia. Am. J. Hematol. 27:157.
10. Murray, J. L., K. C. Loftin, C. G. Munn, J. M. Reuben, P. W. A. Mansell, and E. M. Hersh. 1985. Elevated adenosine deaminase and purine nucleotide phosphorylase in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome. Blood 65:1318.
11. Hirschhorn, R. 1990. Adenosine deaminase deficiency. In Immunodeficiency Reviews, Vol. 2. F. S. Rosen and M. Seligmann, eds. Howard, London, p. 175.
12. Morrison, M. E., S. Vijayasaradhi, D. Engelstein, A. P. Albino, and A. N. Houghton. 1993. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J. Exp. Med. 177:1135.
13. Dong, R.-P., J. Kameoka, M. Hegen, T. Tanaka, Y. Xu, S. F. Schlossman, and C. Morimoto. 1996. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J. Immunol 156:1349.
14. Dinjens, W. N., J. ten Kate, J. T. Wijnen, E. P. M. van der Linden, C. J. L. Beek, M.-H. J. H. Lenders, P. M. Khan, and F. T. Bosman. 1989. Distribution of adenosine deaminase-complexing protein in murine tissues. J. Biol. Chem. 264:19215.
15. Schrader, W. P., C. A. West, A. D. Miczek, and E. K. Norton. 1990. Characterization of the adenosine deaminase-adenosine deaminase complexing protein binding reaction. J. Biol. Chem. 265:19312.
16. Takebe, Y., M. Seiki, J. Fujisawa, P. Hoy, K. Yokota, K. Arai, M. Yoshida, and N. Arai. 1988. SRa promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:466.
17. Martin, M., J. Huguet, J. J. Centelles, and R. Franco. 1995. Expression of ectoadenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex: possible role of adenosine deaminase as costimulatory molecule. J. Immunol. 155:4630.
18. Cronstein B. N., S. B. Kramer, G. Weissmann, and R. Hirschhorn. 1983. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J. Exp. Med. 158:1160.
19. Stiles, G. L. 1992. Adenosine receptors. J. Biol. Chem. 267:6451.
20. Smith, J. W., A. L. Steiner, and C. W. Parker. 1971. Human lymphocyte metabolism: effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J. Clin. Invest. 50:442.
21. Green, H., and T.-S. Chan. 1973. Pyrimidine starvation induced by adenosine in fibroblasts and lymphoid cells: role of adenosine deaminase. Science 182:836.
22. Carson, D. A., and J. E. Seegmiller. 1976. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. J. Clin. Invest. 57:274.
23. Hovi, T., J. F. Smyth, A. C. Allison, and S. C. Williams. 1976. Role of adenosine deaminase in lymphocyte proliferation. Clin. Exp. Immunol. 23:395.
24. Kizaki, H., H. Shimada, F. Ohsaka, and T. Sakurada. 1988. Adenosine, deoxyadenosine and deoxyguanosine induce DNA cleavage in mouse thymocytes. J. Immunol. 141:1652.
25. 2+-mediated mechanisms. Biochem. J. 304:877.
26. Seto, S., C. J. Carrera, M. Kubota, D. B. Wasson, and D. A. Carson. 1985. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J. Clin. Invest. 75:377.
27. Kohn, D. B., H. Mitsuya, M. Ballow, J. E. Selegue, J. Barankiewicz, A. Cohen, E. Gelfand, W. F. Anderson, and R. M. Blaese. 1989. Establishment and characterization of adenosine deaminase-deficient human T cell lines. J. Immunol. 142:3971.
28. Cronstein, B. N., D. Naime, and E. Olstead. 1993. The antiinflammatory mechanism of methotrexate: increased adenosine release at inflamed site diminishes leukocyte accumulation: an in vivo model of inflammation. J. Clin. Invest. 92: 2675.
29. Dang, N. H., Y. Torimoto, K. Shimamura, T. Tanaka, J. F. Daley, S. F. Schlossman, and C. Morimoto. 1991. 1FV (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J. Immunol. 147:2825.
30. Kraut, E. H., M. R. Grever, and B. A. Bouroncle. 1994. Long-term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood. 84:4061.
31. Martin, M., J. M. Aran, D. Colomer, J. Huguet, J. J. Centelles, J. L. Vives-Corrons, and R. Franco. 1994. Surface adenosine deaminase a novel B-cell marker in chronic lymphocytic leukemia. Hum. Immunol. 42:265.
32. Hafler, D. A., D. A. Fox, M. E. Manning, S. F. Schlossman, E. L. Reinherz, and H. L. Weiner. 1985. In vitro activation T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N. Engl. J. Med. 312:1405.
33. Nakao, H., K. Eguchi, A. Kawakami, K. Migita, T. Otsubo, Y. Ueki, C. Shimomura, H. Tezuka, M. Matsunaga, K. Maeda, and S. Nagataki. 1989. Increment of Ta1 positive cells in peripheral blood from patients with rheumatoid arthritis. J. Rheumatol. 16:904.
34. Valenzuela, A., J. Blanco, C. Callebaut, E. Jacotot, C. Lluis, A. C. Hovanessian, and R. Franco. 1997. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles. J. Immunol. 158:3721.